High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I
about
Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IHDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosisCardioprotective functions of HDLsHigh-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblastsPTP1B inhibitor promotes endothelial cell motility by activating the DOCK180/Rac1 pathway.In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and ImagingSR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate CancerNiacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionDesign of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissuesExtrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice.Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbitsPlatelet hyperreactivity, scavenger receptors and atherothrombosis.Neurorestorative therapy for strokeHDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanismsNon-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.Regulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression.Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.Diabetic HDL is dysfunctional in stimulating endothelial cell migration and proliferation due to down regulation of SR-BI expressionClass II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease.Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis.Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhageRegulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen speciesEffect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury modelHigh density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists.Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.PON-dering differences in HDL function in coronary artery disease.PDZK1 prevents neointima formation via suppression of breakpoint cluster region kinase in vascular smooth muscle.A Novel Anti-Inflammatory Effect for High Density Lipoprotein.High-density lipoprotein exerts vasculoprotection via endothelial progenitor cellsApolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress.
P2860
Q24676039-FF4277B7-212B-411B-8A96-81B50D2DE641Q26782972-AF2CE6B1-F144-482A-AFEE-B9798C91CC4EQ27000421-E348DBAF-D6A0-44C0-84A4-79831555D033Q27304363-7AF521D9-EDAD-4EC6-83A1-484063138C18Q27323066-FD0552A9-856D-40C0-90B7-0478EAE64A0BQ27664175-ECD1209B-A806-46D7-BC77-B99989702251Q28070244-1928375C-8A67-4D72-BF7D-C7478EF2F417Q28074790-72F272D9-4DAA-4250-A8C3-A77443C16958Q28086787-7A76D262-638F-4BCF-B4E7-2DA70D18702FQ28235893-D071F8FD-3746-4694-AF6C-8A1E6E16C44AQ28828683-C4910B79-0F5F-4E34-A6F5-0F2A86C2E845Q30528268-5A68B75B-3C5F-4D08-AF7E-662C869216A8Q33402916-C4992D36-E771-414E-BFC4-5DD3AAAC306FQ33504506-96E610E1-51C1-4878-9E23-A4FC4B45EC09Q33565025-E9D91043-83B5-4FBA-98BE-D354DA1D4ACEQ33624492-C0D72850-253E-460A-A858-0DDD5E0E74E8Q33801221-AC946FF1-2456-4301-B69F-BE7F9B289982Q33813333-89628B9A-F9FE-45B0-9AD5-FF6B9E4290AEQ33945091-14D6E15B-9640-4CC6-887E-6322C26614B0Q33967988-DA06E9CE-8C36-4692-A130-A51057815D92Q34076242-C469F6A2-58A6-49F6-AEF3-F7418A39D51BQ34253290-D139C449-D623-4017-9EFF-692425EB21D4Q34335696-AA1468D2-40F6-4CF2-B723-0A15E5C0CBEFQ34469753-3FF54C12-C862-4635-9B60-377A8F994CFEQ34548346-08299926-B125-4C4F-B2D5-1F60C645F2C4Q34575173-2EA51A09-BB26-4F06-8514-C72DE78903AAQ34781496-1FEF0976-8224-49E3-B1A4-A51C38426C42Q34948139-28A7A051-1AD8-41A2-BCA5-BC1EB8058C0BQ35070716-6A2823C8-B2EA-4A3A-B6B3-ABFD49BC25D8Q35152244-EE10D340-1602-443E-87E6-B6055DC256CBQ35216857-2FF1CFAF-EB0A-4568-8294-ED0E85F75713Q35230921-4FAAFA42-8C98-48D6-9E3E-43F9479599F7Q35238369-922058D5-82E5-440E-8EB8-7DD3B2BD9BA7Q35547019-EDA3EB1E-3B99-4D96-BD46-58A8B9E9E7BCQ35572369-41FF0CA8-7A85-40A5-BC4E-60BC23C48871Q35572457-2A4D4F86-F217-4564-A8C5-2B95F4016F19Q35606603-DDD8E35E-5531-4492-B12C-B152B4D472D9Q35872393-C305E3C0-8E33-465C-8CA3-299C28E5D846Q35889139-6B272DDF-6905-494D-AA23-21B5752DEBA4Q35928385-D1436AC9-8EA1-4443-9D08-C2CC4EF4EC46
P2860
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I
description
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/01/06)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/01/06)
@nl
наукова стаття, опублікована в січні 2006
@uk
مقالة علمية (نشرت في 6-1-2006)
@ar
name
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@ast
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@en
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@nl
type
label
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@ast
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@en
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@nl
prefLabel
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@ast
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@en
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@nl
P2093
P921
P3181
P1433
P1476
High-density lipoprotein promo ...... ia scavenger receptor-B type I
@en
P2093
Andrew K. Gormley
Chieko Mineo
Daniel J. Rader
Divya Seetharam
Ken L. Chambliss
Linda L. Gibson
Lisa D. Hahner
Melissa L. Cummings
Philip W. Shaul
Richard L. Kitchens
P3181
P356
10.1161/01.RES.0000199272.59432.5B
P577
2006-01-06T00:00:00Z